Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for antibody to Chlamydia pneumoniae by the complement fixation test

K Fonseca1, C Kluchka, C M Anand

  • 1Provincial Laboratory of Public Health, Foothills Hospital, Calgary, Alberta, Canada.

Diagnostic Microbiology and Infectious Disease
|April 1, 1994
PubMed
Summary

This study examined 120 blood samples that were previously found to be positive for ornithosis antibodies using the complement fixation (CF) test. The researchers used the microimmunofluorescence (MIF) test to check for antibodies to Chlamydia pneumoniae. They found that 60% of the samples were positive for C. pneumoniae, but there was no link between the CF test results and the MIF results. The authors suggest that laboratories using the CF test should also perform the MIF test to confirm whether patients are truly positive for C. pneumoniae. This would help improve the accuracy of diagnoses and better track the spread of the infection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A two-ward acute care hospital outbreak of SARS-CoV-2 delta variant including a point-source outbreak associated with the use of a mobile vital signs cart and sub-optimal doffing of personal protective equipment.

The Journal of hospital infection·2022
Same author

Genetic characterization of measles virus genotype D6 subacute sclerosing panencephalitis case, Alberta, Canada.

Journal of neurovirology·2018
Same author

Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2015
Same author

Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2014
Same author

Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2013
Same author

Hepatitis E in a Canadian traveller.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses·2012

Area of Science:

  • Clinical microbiology
  • Immunological testing methods
  • Infectious disease diagnostics

Background:

Prior research has shown that Chlamydia pneumoniae is a common respiratory pathogen. It was already known that the complement fixation test is a standard method for detecting antibodies to ornithosis antigens. However, the relationship between these results and C. pneumoniae remains unclear. This gap motivated a need to explore cross-reactivity between the two. No prior work had resolved whether positivity for ornithosis antigen correlates with C. pneumoniae serology. The lack of clarity affects both clinical interpretation and public health tracking. Researchers have long debated the reliability of cross-reactive tests in this context. This uncertainty drives the need for more specific diagnostic approaches.

Purpose Of The Study:

The aim of this study was to evaluate the relationship between antibody responses to ornithosis antigen and C. pneumoniae. The researchers focused on sera previously identified as positive for ornithosis. They wanted to determine whether these samples also showed reactivity to C. pneumoniae. The motivation was to improve diagnostic accuracy in clinical settings. The study sought to clarify the limitations of the complement fixation test. The team aimed to assess the need for additional testing methods. They wanted to provide guidance for laboratories using the CF test. The goal was to support better epidemiological and clinical decision-making.

Keywords:
Chlamydia pneumoniaeantibody detectioncomplement fixation testmicroimmunofluorescence testserological testing

Frequently Asked Questions

The study found no association between CF test results for ornithosis and C. pneumoniae antibody titers.

The MIF test was used to detect specific IgG and IgM antibodies to C. pneumoniae.

The CF test does not distinguish between ornithosis and C. pneumoniae antibodies.

The MIF test provides more specific detection of C. pneumoniae antibodies than the CF test.

Sixty percent of the patients were serologically positive for C. pneumoniae.

Related Experiment Videos

Main Methods:

The researchers used a retrospective survey approach with 120 sera samples. These samples were previously identified as positive for ornithosis antigen. They applied the microimmunofluorescence (MIF) test to detect C. pneumoniae antibodies. The panel included 40 paired acute and convalescent samples. Another 40 samples were single, from 80 patients in total. The MIF test measured IgG and IgM antibody titers. The team compared these results to the original CF test findings. They analyzed the correlation between CF and MIF results for both IgG and IgM.

Main Results:

Sixty percent of the patients were serologically positive for C. pneumoniae. The MIF test detected IgG, IgM, or both in these individuals. No significant association was found between CF titers and MIF titers. The CF test results for ornithosis antigen did not predict C. pneumoniae reactivity. The IgG and IgM levels in the MIF test varied independently of the CF results. The absence of correlation suggests no direct relationship between the two tests. The findings indicate that the CF test is not reliable for C. pneumoniae detection. The study highlights the need for additional testing in positive CF cases.

Conclusions:

The authors propose that laboratories using the CF test should perform further testing for C. pneumoniae. They suggest the MIF test as a more specific method for confirming serological status. The findings imply that CF positivity for ornithosis does not equate to C. pneumoniae infection. The lack of correlation supports the need for additional diagnostic steps. The study emphasizes the importance of accurate serological interpretation. The authors highlight the value of MIF testing in clinical and epidemiological contexts. They recommend integrating MIF into routine testing protocols. This approach would improve diagnostic clarity and public health tracking.

The authors propose using the MIF test to confirm C. pneumoniae status in CF-positive cases.